AbdulSalam SF, Thowfeik FS, Merino EJ Excessive Reactive Oxygen Species and Exotic DNA Lesions as an Exploitable Liability. Biochemistry. 2016; 55:5341-5352.
Adesanoye OA, Farombi EO Hepatoprotective effects of Vernonia amygdalina (astereaceae) in rats treated with carbon tetrachloride. Exp Toxicol Pathol. 2010; 62:197-206.
Albert JM, Liu DD, Shen Y et al. Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol. 2012; 30:2837-2843.
Bezan A, Mrsic E, Krieger D et al. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma. J Urol. 2015; 194:30-35.
Camp RL, Dolled-Filhart M, Rimm DL X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10:7252-7259.
Chen SL, Li JP, Li LF et al. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma. International journal of molecular sciences. 2016; 17.
Concepcion Navarro M, Pilar Montilla M, Martin A et al. Free radical scavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med. 1993; 59:312-314.
Drotman RB, Lawhorn GT Serum enzymes as indicators of chemically induced liver damage. Drug Chem Toxicol. 1978; 1:163-171.
Frederiks WM, Vogels IM, Fronik GM Plasma ornithine carbamyl transferase level as an indicator of ischaemic injury of rat liver. Cell Biochem Funct. 1984; 2:217-220.
Fujitani K, Kurokawa Y, Takeno A et al. Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer? Gastric Cancer. 2018; 21:446-452.
Fulda S, Gorman AM, Hori O et al. Cellular stress responses: cell survival and cell death. Int J Cell Biol. 2010; 2010:214074.
Gleeson D, Jones JS, McFarlane E et al. Severity of alcohol dependence in decompensated alcoholic liver disease: comparison with heavy drinkers without liver disease and relationship to family drinking history. Alcohol Alcohol. 2009; 44:392-397.
Ishihara H, Kondo T, Yoshida K et al. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study. Clin Genitourin Cancer. 2017; 15:598-604.
Kawamoto R, Kohara K, Kusunoki T et al. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012; 11:117.
Li X, Fang P, Mai J et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013; 6:19.
Li Y, Jia H, Yu W et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer. 2016; 139:220-231.
Lin MS, Lin HS, Chung CM et al. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study. BMJ Open. 2015; 5:e008797.
Liu X, Wu Z, Lin E et al. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy. Clin Nutr. 2018.
Mbulaiteye SM, Hisada M, El-Omar EM Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed). 2009; 14:1490-1504.
Noh SH, Park SR, Yang HK et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014; 15:1389-1396.
Nyblom H, Bjornsson E, Simren M et al. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int. 2006; 26:840-845.
Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94:153-156.
Sasako M, Sakuramoto S, Katai H et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011; 29:4387-4393.
Siegel RL, Miller KD, Jemal A Cancer statistics, 2016. CA Cancer J Clin. 2016; 66:7-30.
Sternberg CN Are nomograms better than currently available stage groupings for bladder cancer? J Clin Oncol. 2006; 24:3819-3820.
Takahashi T, Saikawa Y, Kitagawa Y Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013; 5:48-63.
Talley NJ, Zinsmeister AR, Weaver A et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991; 83:1734-1739.
Thornburg JM, Nelson KK, Clem BF et al. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res. 2008; 10:R84.
Toiyama Y, Inoue Y, Saigusa S et al. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Anticancer Res. 2013; 33:5065-5074.
Valentini V, van Stiphout RG, Lammering G et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011; 29:3163-3172.
Wolf PL Biochemical diagnosis of liver disease. Indian J Clin Biochem. 1999; 14:59-90.
Yamaoka Y, Kato M, Asaka M Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med. 2008; 47:1077-1083.
Zeng Q, Xue N, Dai D et al. A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer. J Cancer. 2017; 8:744-753.
Zhang JP, Wang HB, Lin YH et al. Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy. Transl Oncol. 2015; 8:497-503.
Zou Q, Li J, Wu D et al. Nomograms for Pre-operative and Post-operative Prediction of Long-Term Survival of Patients Who Underwent Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma. Ann Surg Oncol. 2016; 23:2618-2626.